FREQ - Frequency Therapeutics GAAP EPS of -$0.61 August, 09 2022 05:20 PM Frequency Therapeutics Inc. Frequency Therapeutics press release ( NASDAQ: FREQ ): Q2 GAAP EPS of -$0.61. Cash, cash equivalents and marketable securities as of June 30, 2022, were $111.0 million (excluding restricted cash). For further details see: Frequency Therapeutics GAAP EPS of -$0.61